FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient’s menopausal status.
.png)
No hay comentarios:
Publicar un comentario